Deciphering the mysteries of MEG3 LncRNA and its implications in genitourinary cancers [PDF]
Frontiers in OncologyMaternally expressed gene 3 (MEG3), a long non-coding RNA, plays a pivotal role in various biological processes, including tumorigenesis. Aberrant expression of MEG3 has been implicated in several cancers, including genitourinary malignancies.
Reem A. Assal +6 more
doaj +4 more sources
Global, regional, and national burden of genitourinary cancers in 204 countries and territories, 1990–2021: a systematic analysis for the global burden of disease study 2021 [PDF]
Journal of the National Cancer CenterBackground: Genitourinary cancers constitute a significant portion of the global cancer burden and have emerged as a prominent cause of cancer-related mortality.
Zhiyong Zhang +18 more
doaj +4 more sources
Research progress of MUC1 in genitourinary cancers [PDF]
Cellular & Molecular Biology LettersMUC1 is a highly glycosylated transmembrane protein with a high molecular weight. It plays a role in lubricating and protecting mucosal epithelium, participates in epithelial cell renewal and differentiation, and regulates cell adhesion, signal ...
Weipu Mao +4 more
doaj +3 more sources
Awareness of Genitourinary Cancers Risk Factors—A 2024 Population-Based Cross-Sectional Study in Poland [PDF]
International Journal of Public HealthObjectiveThis study aimed to assess the awareness of genitourinary cancers risk factors among adults in Poland and to identify factors associated with public awareness of risk factors for genitourinary cancers.MethodsThis cross-sectional survey was ...
Gabriela Moczeniat +4 more
doaj +4 more sources
Precision surgery and genitourinary cancers [PDF]
European Journal of Surgical Oncology (EJSO), 2017 The landscape of the surgical management of urologic malignancies has dramatically changed over the past 20 years. On one side, better diagnostic and prognostic tools allowed better patient selection and more reliable surgical planning. On the other hand, the implementation of minimally invasive techniques and technologies, such as robot-assisted ...
Autorino, R. +9 more
core +9 more sources
Examining the trend of mortality of genitourinary system cancers in Babol, North Iran (2013–2021)
BMC UrologyBackground Cancers of the genitourinary system, particularly prostate, bladder, and kidney cancer, exhibit a high prevalence. Consequently, predicting the morbidity and mortality of genitourinary cancers holds great significance for future planning and ...
Pouyan Ebrahimi +6 more
doaj +2 more sources
Mechanisms of Progranulin Action and Regulation in Genitourinary Cancers [PDF]
Frontiers in Endocrinology, 2016 The growth factor progranulin has emerged in recent years as a critical regulator of transformation in several cancer models, including breast cancer, glioblastomas, leukemias and hepatocellular carcinomas. Several laboratories, including ours, have also
Ryuta Tanimoto +6 more
doaj +3 more sources
Genitourinary cancers updates: highlights from ASCO 2023 [PDF]
Journal of Hematology & Oncology, 2023 Significant scientific advances in immunotherapy and targeted therapy approaches have improved clinical outcomes and increased treatment options for patients with genitourinary (GU) malignancies.
Qian Qin +4 more
doaj +2 more sources
Alcohol consumption among patients diagnosed with genitourinary cancers [PDF]
BJUI CompassObjective To characterize alcohol consumption and binge‐drinking patterns among individuals with GU cancers (prostate, kidney, bladder and testicular) compared to a propensity‐matched cohort without cancer in a large, nationally diverse population ...
Aidan Weitzner +4 more
doaj +2 more sources
Advances in medical treatments for genitourinary cancers
Revista Médica Clínica Las Condes, 2018 Genitourinary (GU) cancers are amongst the most common cancer types, especially neoplasms of the prostate, bladder and kidney. While cure can often only be achieved surgically at early stages, management of advanced or metastatic disease requires ...
Felix Wezel, MD, MSc +1 more
doaj +2 more sources